Fiber and functional gastrointestinal disorders

American Journal of Gastroenterology

Volumn 108, Issue 5, 2013, Pages 718-727

  Eswaran, Shanti ^a   Muir, Jane ^b   Chey, William D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISPAGULA; SHORT CHAIN FATTY ACID;

ABDOMINAL DISTENSION; ARTICLE; COLON; CONSTIPATION; DIARRHEA; DIETARY INTAKE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; FERMENTATION; FIBER; FLATULENCE; GAS; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE FLORA; IRRITABLE COLON; METABOLISM; PRIORITY JOURNAL; SENSATION; SMALL INTESTINE;

ABDOMINAL PAIN; CONSTIPATION; DIARRHEA; DIETARY FIBER; EVIDENCE-BASED MEDICINE; FERMENTATION; FLATULENCE; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84877576682     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.63     Document Type: Article

References (126)

1. Bouchoucha M, Faye A, Savarieau B et al. Effect of an oral bulking agent and a rectal laxative administered alone or in combination for the treatment of constipation . Gastroenterol Clin Biol 2004; 28: 438-43.
2. Ramkumar D, Rao SS . Effi cacy and safety of traditional medical therapies for chronic constipation: systematic review . Am J Gastroenterol 2005; 100: 936-71.
3. McRorie JW, Daggy BP, Morel JG et al. Psyllium is superior to docusate sodium for treatment of chronic constipation . Aliment Pharmacol Ther 1998; 12: 491-7.
4. Mehmood MH, Aziz N, Ghayur MN et al. Pharmacological basis for the medicinal use of psyllium husk (Ispaghula) in constipation and diarrhea. Dig Dis Sci 2011; 56: 1460-71.
5. Washington N, Harris M, Mussellwhite A et al. Moderation of lactuloseinduced diarrhea by psyllium: Effects on motility and fermentation. Am J Clin Nutr 1998; 67: 317-21.
6. Wenzl HH, Fine KD, Schiller LR et al. Determinants of decreased fecal consistency in patients with diarrhea . Gastroenterology 1995; 108 : 1729-38.
7. Qvitzau S, Matzen P, Madsen P . Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium . Scand J Gastroenterol 1988; 23: 1237-40.
8. Heather DJ, Howell L, Montana M et al. Effect of a bulk-forming cathartic on diarrhea in tube-fed patients . Heart Lung 1991; 20: 409-13.
9. Eherer AJ, Santa Ana CA, Porter J et al. Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein . Gastroenterology 1993; 104: 1007-12.
10. Murphy J, Stacey D, Crook J et al. Testing control of radiation-induced diarrhea with a psyllium bulking agent: a pilot study . Can Oncol Nurs J 2000; 10: 96-100.
11. Smalley JR, Klish WJ, Campbell MA et al. Use of psyllium in the management of chronic nonspecifi c diarrhea of childhood . J Pediatr Gastroenterol Nutr 1982; 1: 361-3.
12. Sherman DS, Fish DN . Management of protease inhibitor-associated diarrhea . Clin Infect Dis 2000; 30: 908-14.
13. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL et al. Randomized clinical trial of Plantago ovata seeds (dietary fi ber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish group for the study of Crohn's disease and ulcerative colitis (GETECCU). Am J Gastroenterol 1999; 94: 427-33.
14. Fujimori S, Gudis K, Mitsui K et al. A randomized controlled trial on the effi cacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis . Nutrition 2009; 25 : 520-5.
15. Fujimori S, Tatsuguchi A, Gudis K et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease . J Gastroenterol Hepatol 2007; 22: 1199-204.
16. Pittler MH, Ernst E . Dietary supplements for body-weight reduction: a systematic review . Am J Clin Nutr 2004; 79: 529-36.
17. Salas-Salvado J, Farres X, Luque X et al. Effect of two doses of a mixture of soluble fi bres on body weight and metabolic variables in overweight or obese patients: a randomised trial . Br J Nutr 2008; 99: 1380-7.
18. Rodriguez-Moran M, Guerrero-Romero F, Lazcano-Burciaga G . Lipid-and glucose-lowering effi cacy of Plantago Psyllium in type II diabetes. J Diabetes Complications 1998; 12: 273-8.
19. Moreyra AE, Wilson AC, Koraym A . Effect of combining psyllium fi ber with simvastatin in lowering cholesterol . Arch Intern Med 2005; 165 : 1161-6.
20. Romero AL, West KL, Zern T et al. The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs. J Nutr 2002; 132: 1194-8.
21. de Bock M, Derraik JG, Brennan CM et al. Psyllium supplementation in adolescents improves fat distribution & lipid profi le: a randomized, participant-blinded, placebo-controlled, crossover trial . PLoS One 2012; 7: e41735.
22. Anderson JW, Allgood LD, Turner J et al. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia . Am J Clin Nutr 1999; 70: 466-73.
23. Levin EG, Miller VT, Muesing RA et al. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia . Arch Intern Med 1990; 150: 1822-7.
24. Pastors JG, Blaisdell PW, Balm TK et al. Psyllium fi ber reduces rise in postprandial glucose and insulin concentrations in patients with noninsulin-dependent diabetes . Am J Clin Nutr 1991; 53: 1431-5.
25. Sierra M, Garcia JJ, Fernandez N et al. Therapeutic Effects of psyllium in type 2 diabetic patients . Eur J Clin Nutr 2002; 56: 830-42.
26. Slavin JL . Position of the American Dietetic Association: health implications of dietary fi ber . J Am Diet Assoc 2008; 108: 1716-31.
27. Cummings JH, Macfarlane GT . The control and consequences of bacterial fermentation in the human colon . J Appl Bacteriol 1991; 70: 443-59.
28. Cummings JH, Macfarlane GT, Englyst HN . Prebiotic digestion and fermentation . Am J Clin Nutr 2001; 73: 415S-20S.
29. Todesco T, Rao AV, Bosello O et al. Propionate lowers blood glucose and alters lipid metabolism in healthy subjects . Am J Clin Nutr 1991; 54: 860-5.
30. Topping DL, Clifton PM . Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81: 1031-64.
31. Roediger WE . Utilization of nutrients by isolated epithelial cells of the rat colon . Gastroenterology 1982; 83: 424-9.
32. Flamm G, Glinsmann W, Kritchevsky D et al. Inulin and oligofructose as dietary fi ber: a review of the evidence . Crit Rev Food Sci Nutr 2001; 41: 353-62.
33. Davies GJ, Crowder M, Reid B et al. Bowel function measurements of individuals with diff erent eating patterns . Gut 1986; 27: 164-9.
34. McRorie J, Greenwood-Van Meerveld B, Rudolph C . Characterization of propagating contractions in proximal colon of ambulatory mini pigs. Dig Dis Sci 1998; 43: 957-63.
35. Heizer WD, Southern S, McGovern S . The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review . J Am Diet Assoc 2009; 109: 1204-14.
36. Chouinard LE . The role of psyllium fi bre supplementation in treating irritable bowel syndrome . Can J Diet Pract Res 2011; 72: e107-14.
37. Bijkerk CJ, Muris JW, Knottnerus JA et al. Systematic review: the role of diff erent types of fi bre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004; 19: 245-51.
38. Biesiekierski JR, Rosella O, Rose R et al. Quantifi cation of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals . J Hum Nutr Diet 2011; 24: 154-76.
39. Hunt R, Fedorak R, Frohlich J et al. Therapeutic role of dietary fi bre. Can Fam Physician 1993; 39: 897-900, 3-10.
40. Elia M, Cummings JH . Physiological aspects of energy metabolism and gastrointestinal Effects of carbohydrates . Eur J Clin Nutr 2007; 61 (Suppl 1) : S40-74.
41. Burkitt DP, Walker AR, Painter NS . Effect of dietary fi bre on stools and the transit-times, and its role in the causation of disease . Lancet 1972; 2: 1408-12.
42. Stephen AM, Cummings JH . Mechanism of action of dietary fi bre in the human colon . Nature 1980; 284: 283-4.
43. Tomlin J, Read NW . The relation between bacterial degradation of viscous polysaccharides and stool output in human beings . Br J Nutr 1988; 60: 467-75.
44. Riottot M, Sacquet E, Leprince C . Effect of wheat bran upon gastrointestinal transit in germ-free and conventional rats . Digestion 1984; 29 : 37-41.
45. Tomlin J, Read NW . Laxative properties of indigestible plastic particles. BMJ 1988; 297: 1175-6.
46. Lewis SJ, Heaton KW . Roughage revisited: the Effect on intestinal function of inert plastic particles of diff erent sizes and shape . Dig Dis Sci 1999; 44: 744-8.
47. Camilleri M . Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-68.
48. Camilleri M, Heading RC, Thompson WG . Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther 2002; 16: 1407-30.
49. Hamer HM, Jonkers D, Venema K et al. Review article: the role of butyrate on colonic function . Aliment Pharmacol Ther 2008; 27: 104-19.
50. Gonlachanvit S, Coleski R, Owyang C et al. Inhibitory actions of a high fi bre diet on intestinal gas transit in healthy volunteers . Gut 2004; 53: 1577-82.
51. McRorie J, Pepple S, Rudolph C . Effects of fi ber laxatives and calcium docusate on regional water content and viscosity of digesta in the large intestine of the pig . Dig Dis Sci 1998; 43: 738-45.
52. Marlett JA, Fischer MH . The active fraction of psyllium seed husk. Proc Nutr Soc 2003; 62: 207-9.
53. Bergmann JF, Chassany O, Petit A et al. Correlation between echographic gastric emptying and appetite: infl uence of psyllium . Gut 1992; 33: 1042-3.
54. Rigaud D, Paycha F, Meulemans A et al. Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study . Eur J Clin Nutr 1998; 52: 239-45.
55. Bianchi M, Capurso L . Effects of guar gum, ispaghula and microcrystalline cellulose on abdominal symptoms, gastric emptying, orocaecal transit time and gas production in healthy volunteers . Dig Liver Dis 2002; 34 (Suppl 2): S129-33.
56. Frost GS, Brynes AE, Dhillo WS et al. The Effects of fi ber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal . Eur J Clin Nutr 2003; 57: 293-8.
57. Kawasaki N, Suzuki Y, Urashima M et al. Effect of gelatinization on gastric emptying and absorption . Hepatogastroenterology 2008; 55: 1843-5.
58. Grimes DS, Goddard J . Gastric emptying of wholemeal and white bread. Gut 1977; 18: 725-9.
59. Meyer JH, Gu Y, Elashoff J et al. Effects of viscosity and fl uid outfl ow on postcibal gastric emptying of solids . Am J Physiol 1986; 250: G161-4.
60. Russell J, Bass P . Canine gastric emptying of fi ber meals: infl uence of meal viscosity and antroduodenal motility . Am J Physiol 1985; 249: G662-7.
61. Vincent R, Roberts A, Frier M et al. Effect of bran particle size on gastric emptying and small bowel transit in humans: a scintigraphic study. Gut 1995; 37: 216-9.
62. Timm DA, Stewart ML, Hospattankar A et al. Wheat dextrin, psyllium, and inulin produce distinct fermentation patterns, gas volumes, and shortchain fatty acid profi les in vitro . J Med Food 2010; 13: 961-6.
63. Soret R, Chevalier J, De Coppet P et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 2010; 138: 1772-82.
64. Jouet P, Sabate JM, Coffin B et al. Fermentation of starch stimulates propagated contractions in the human colon . Neurogastroenterol Motil 2011; 23: 450-6, e176.
65. Zimmerman MA, Singh N, Martin PM et al. Butyrate suppresses colonic infl ammation through HDAC1-dependent Fas Upregulation and Fasmediated apoptosis of T cells . Am J Physiol Gastrointest Liver Physiol 2012; 302: 61405-15.
66. Klampfer L, Huang J, Sasazuki T et al. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate . Mol Cancer Res 2003; 1 : 855-62.
67. Stempelj M, Kedinger M, Augenlicht L et al. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate . J Biol Chem 2007; 282: 9797-804.
68. Ropert A, Cherbut C, Roze C et al. Colonic fermentation and proximal gastric tone in humans . Gastroenterology 1996; 111: 289-96.
69. Piche T, Zerbib F, Varannes SB et al. Modulation by colonic fermentation of LES function in humans . Am J Physiol Gastrointest Liver Physiol 2000; 278: G578-84.
70. Piche T, des Varannes SB, Sacher-Huvelin S et al. Colonic fermentation infl uences lower esophageal sphincter function in gastroesophageal refl ux disease . Gastroenterology 2003; 124: 894-902.
71. Roberfroid M . Prebiotics: the concept revisited . J Nutr 2007; 137: 830S-7S.
72. Gibson GR, Beatty ER, Wang X et al. Selective stimulation of bifi dobacteria in the human colon by oligofructose and inulin . Gastroenterology 1995; 108: 975-82.
73. Bouhnik Y, Flourie B, Riottot M et al. Effects of fructo-oligosaccharides ingestion on fecal bifi dobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans . Nutr Cancer 1996; 26: 21-9.
74. Kleessen B, Sykura B, Zunft HJ et al. Effects of inulin and lactose on fecal microfl ora, microbial activity, and bowel habit in elderly constipated persons . Am J Clin Nutr 1997; 65: 1397-402.
75. Roberfroid MB, Van Loo JA, Gibson GR . The bifi dogenic nature of chicory inulin and its hydrolysis products . J Nutr 1998; 128: 11-9.
76. Silk DB, Davis A, Vulevic J et al. Clinical trial: the Effects of a transgalactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome . Aliment Pharmacol Ther 2009; 29: 508-18.
77. Trowell H . Defi nition of dietary fi ber and hypotheses that it is a protective factor in certain diseases . Am J Clin Nutr 1976; 29: 417-27.
78. Burkitt DP, Meisner P . How to manage constipation with high-fi ber diet. Geriatrics 1979; 34: 33-5, 8-40.
79. Tucker DM, Sandstead HH, Logan Jr GM et al. Dietary fi ber and personality factors as determinants of stool output . Gastroenterology 1981; 81: 879-83.
80. Johanson JF, Kralstein J . Chronic constipation: a survey of the patient perspective . Aliment Pharmacol Ther 2007; 25: 599-608.
81. Locke 3rd GR, Pemberton JH, Phillips SF . AGA technical review on constipation. American Gastroenterological Association . Gastroenterology 2000; 119: 1766-78.
82. Rao SS . Constipation: evaluation and treatment of colonic and anorectal motility disorders . Gastroenterol Clin North Am 2007; 36: 687-711, x.
83. Marteau P, Flourie B, Cherbut C et al. Digestibility and bulking Effect of ispaghula husks in healthy humans . Gut 1994; 35: 1747-52.
84. Payler DK, Pomare EW, Heaton KW et al. The Effect of wheat bran on intestinal transit . Gut 1975; 16: 209-13.
85. Tramonte SM, Brand MB, Mulrow CD et al. The treatment of chronic constipation in adults. A systematic review . J Gen Intern Med 1997; 12 : 15-24.
86. Jones MP, Talley NJ, Nuyts G et al. Lack of objective evidence of effi cacy of laxatives in chronic constipation . Dig Dis Sci 2002; 47: 2222-30.
87. Irvine EJ, Whitehead WE, Chey WD et al. Design of treatment trials for functional gastrointestinal disorders . Gastroenterology 2006; 130 : 1538-51.
88. Suares NC, Ford AC . Systematic review: the Effects of fi bre in the management of chronic idiopathic constipation . Aliment Pharmacol Ther 2011; 33: 895-901.
89. Fenn GC, Wilkinson PD, Lee CE et al. A general practice study of the effi cacy of Regulan in functional constipation . Br J Clin Pract 1986; 40 : 192-7.
90. Ashraf W, Park F, Lof J et al. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation . Aliment Pharmacol Ther 1995; 9: 639-47.
91. Nunes F, Nunes C, Levis E . A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation. Rev Bras Med 2005; 62: 352-7.
92. Lopez Roman J, Martinez Gonzalvez A, Luque A . Efecto de la ingesta de un preparado lacteo con fi bra dietetica sobre el estrenimiento cronic primario idiopatico . Nutr Hosp 2008; 23: 12-9.
93. Badiali D, Corazziari E, Habib FI et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995; 40: 349-56.
94. Hongisto SM, Paajanen L, Saxelin M et al. A combination of fi bre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation . Eur J Clin Nutr 2006; 60: 319-24.
95. Hamilton JW, Wagner J, Burdick BB et al. Clinical evaluation of methylcellulose as a bulk laxative . Dig Dis Sci 1988; 33: 993-8.
96. Voderholzer WA, Schatke W, Muhldorfer BE et al. Clinical response to dietary fi ber treatment of chronic constipation . Am J Gastroenterol 1997; 92: 95-8.
97. Mertz H, Naliboff B, Mayer E . Physiology of refractory chronic constipation . Am J Gastroenterol 1999; 94: 609-15.
98. Schiller LR . Review article: the therapy of constipation . Aliment Pharmacol Ther 2001; 15: 749-63.
99. Attaluri A, Donahoe R, Valestin J et al. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation . Aliment Pharmacol Ther 2011; 33: 822-8.
100. McRorie J, Zorich N, Riccardi K et al. Effects of olestra and sorbitol consumption on objective measures of diarrhea: impact of stool viscosity on common gastrointestinal symptoms . Regul Toxicol Pharmacol 2000; 31: 59-67.
101. Painter NS . Irritable or irritated bowel . Br Med J 1972; 2: 46.
102. Manning AP, Heaton KW, Harvey RF . Wheat fi bre and irritable bowel syndrome. A controlled trial . Lancet 1977; 2: 417-8.
103. Prior A, Whorwell PJ . Double blind study of ispaghula in irritable bowel syndrome . Gut 1987; 28: 1510-3.
104. Lambert JP, Brunt PW, Mowat NA et al. The value of prescribed ' high-fi bre ' diets for the treatment of the irritable bowel syndrome. Eur J Clin Nutr 1991; 45: 601-9.
105. Francis CY, Whorwell PJ . Bran and irritable bowel syndrome: time for reappraisal . The Lancet 1994; 344: 39-40.
106. Bijkerk CJ, de Wit NJ, Stalman WA et al. Irritable bowel syndrome in primary care: the patients ' and doctors ' views on symptoms, etiology and management . Can J Gastroenterol 2003; 17: 363-8, quiz 405-6.
107. Saito YA, Locke ## 3rd GR, Weaver AL et al. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol 2005; 100: 2743-8.
108. Bohn N, Storsrud S, Lindh A et al. Nutrition intake in patients with irritable bowel syndrome (IBS) compared with the general population. Gastroenterology 2011; 140: S305.
109. Ford AC, Talley NJ, Spiegel BM et al. Effect of fi bre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis . BMJ 2008; 337: a2313.
110. Lesbros-Pantoflickova D, Michetti P, Fried M et al. Meta-analysis: The treatment of irritable bowel syndrome . Aliment Pharmacol Ther 2004; 20: 1253-69.
111. Brandt LJ, Chey WD, Foxx-Orenstein AE et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 (Suppl 1): S1-35.
112. Ruepert L, Quartero AO, de Wit NJ et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011, CD003460.
113. Jailwala J, Imperiale TF, Kroenke K . Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000; 133: 136-47.
114. Zuckerman MJ . The role of fi ber in the treatment of irritable bowel syndrome: therapeutic recommendations . J Clin Gastroenterol 2006; 40: 104-8.
115. Akehurst R, Kaltenthaler E . Treatment of irritable bowel syndrome: a review of randomised controlled trials . Gut 2001; 48: 272-82.
116. Bijkerk CJ, de Wit NJ, Muris JW et al. Soluble or insoluble fi bre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009; 339: b3154.
117. Miller V, Lea R, Agrawal A et al. Bran and irritable bowel syndrome: the primary-care perspective . Dig Liver Dis 2006; 38: 737-40.
118. Parisi G, Bottona E, Carrara M et al. Treatment Effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial. Dig Dis Sci 2005; 50: 1107-12.
119. Parisi GC, Zilli M, Miani MP et al. High-fi ber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG) . Dig Dis Sci 2002; 47: 1697-704.
120. Toskes PP, Connery KL, Ritchey TW . Calcium polycarbophil compared with placebo in irritable bowel syndrome . Aliment Pharmacol Ther 1993; 7: 87-92.
121. Aller R, de Luis DA, Izaola O et al. Effects of a high-fi ber diet on symptoms of irritable bowel syndrome: a randomized clinical trial. Nutrition 2004; 20: 735-7.
122. Lucey MR, Clark ML, Lowndes J et al. Is bran effi cacious in irritable bowel syndrome? A double blind placebo controlled crossover study. Gut 1987; 28: 221-5.
123. Villagrasa M, Boix J, Humbert P et al. Aleatory clinical study comparing otilonium bromide with a fi ber-rich diet in the treatment of irritable bowel syndrome . Ital J Gastroenterol 1991; 23: 67-70.
124. Shepherd SJ, Parker FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence . Clin Gastroenterol Hepatol 2008; 6 : 765-71.
125. Nanda RRJ, Smith H, Dudley CR, Jewell DP . Food intolerance and the irritable bowel syndrome . Gut 1989; 30: 1099-104.
126. King TS, Elia M, Hunter JO . Abnormal colonic fermentation in irritable bowel syndrome . Lancet 1998; 352: 1187-9.